SK136693A3 - Therapeutic compositions for osteoinduction - Google Patents

Therapeutic compositions for osteoinduction Download PDF

Info

Publication number
SK136693A3
SK136693A3 SK1366-93A SK136693A SK136693A3 SK 136693 A3 SK136693 A3 SK 136693A3 SK 136693 A SK136693 A SK 136693A SK 136693 A3 SK136693 A3 SK 136693A3
Authority
SK
Slovakia
Prior art keywords
bmp
vitamin
dihydroxy
compound
safe
Prior art date
Application number
SK1366-93A
Other languages
English (en)
Slovak (sk)
Inventor
Roger L Stone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK136693A3 publication Critical patent/SK136693A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1366-93A 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction SK136693A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US85611092A 1992-03-27 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (1)

Publication Number Publication Date
SK136693A3 true SK136693A3 (en) 1994-10-05

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1366-93A SK136693A3 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0601135B1 (en) * 1991-08-30 2005-11-02 Curis, Inc. Osteogenic proteins in the treatment of metabolic bone diseases
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
CN1104257C (zh) * 1993-03-29 2003-04-02 津莫吉尼蒂克斯公司 含pdgf和维生素d的刺激成骨细胞生长的组合物
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
EP2332564A1 (en) * 1997-02-07 2011-06-15 Stryker Corporation Matrix-free osteogenic devices, implants and methods thereof
JP4255382B2 (ja) * 2001-10-31 2009-04-15 アルコン，インコーポレイテッド 骨形成タンパク質（ｂｍｐ）、ｂｍｐレセプターおよびｂｍｐ結合タンパク質ならびに緑内障の診断および処置におけるそれらの使用
CN104257667B (zh) * 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
US20100204123A1 (en) * 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
CA2752160A1 (en) * 2009-02-12 2010-08-19 Stryker Corporation Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
CA2110410C (en) 1997-04-15
EP0587751A1 (en) 1994-03-23
WO1992021365A1 (en) 1992-12-10
PT100567A (pt) 1994-01-31
NZ243018A (en) 1995-12-21
AU2145492A (en) 1993-01-08
IE921812A1 (en) 1992-12-16
CZ262493A3 (en) 1994-07-13
BR9206110A (pt) 1995-07-11
CA2110410A1 (en) 1992-12-10
NO934381D0 (no) 1993-12-02
AU667815B2 (en) 1996-04-18
NO934381L (no) 1994-01-31
JPH06508140A (ja) 1994-09-14
RU2107512C1 (ru) 1998-03-27
CZ282231B6 (cs) 1997-06-11

Similar Documents

Publication Publication Date Title
US5693615A (en) Therapeutic compositions for osteoinduction
EP0679097B1 (en) Tgf-beta formulation for inducing bone growth
US7498021B2 (en) Dental products comprising bone growth enhancing peptide
EP0436469B1 (en) Composition and method for the treatment of osteoporosis in mammals
SK136693A3 (en) Therapeutic compositions for osteoinduction
JPH09510209A (ja) 骨の成長を刺激するための繊維芽細胞成長因子の用途
US9089606B2 (en) Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases
JPH10512235A (ja) 骨形成の促進および骨再造形の調節のためのｉｇｆ／ｉｇｆｂｐ複合体
CA2105997A1 (en) Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
JPH07504160A (ja) 骨の再生
US20080107706A1 (en) Osteogenic Oligonucleotides and Uses Thereof
JPH10203995A (ja) 抗骨粗鬆症剤
Parimala Comparative evaluation of bovine porous bone mineral (Bio-Oss) bone craft with and without platelet rich plasma (PRP) in the treatment of periodontal intrabony defects: a clinical study